Title: Workforce Health From Cost to Value
1Workforce Health-- From Cost to Value --
- Bill Molmen, J.D.
- Co-Founder and General Counsel
- Integrated Benefits Institute
2Whats the Real Issue?
3National Healthcare Expenditures
Projected
Actual
Source CMS, Office of the Actuary, National
Health Statistics Group.
4Then, The Solution
Plan Design
Healthcare Costs
5Or This?
6Leveraging Human Capital
Company
7Demonstrating Healthcare Business Value
Health Status
Business Impacts
8About IBI
- National, non-profit
- 400 corporate sponsors
- Programs
- Research
- Health productivity measurement
- Benchmarking
- Education
9How Can Senior Management be a Change Agent?
10(No Transcript)
11Linking Health, Productivity the Bottom Line
12CFOs Dont Abide Ill Health
96
90
No Difference
86
84
Source The Business Value of Health Linking
CFOs to Health and Productivity, IBI, 2006
13Are CFOs Getting Lost-time Information?
- Absence
- 51 ever get reports on occurrence
- 22 get reports on financial impact
- Presenteeism
- 22 ever get reports on occurrence
- 8 get reports on financial impact
Source The Business Value of Health Linking
CFOs to Health and Productivity, IBI, 2006
14Lost Work Time Criticality
49
Source The Business Value of Health Linking
CFOs to Health and Productivity, IBI, 2006
15How CFOs Would Use Lost- Productivity
Information
Source The Business Value of Health Linking
CFOs to Health and Productivity, IBI, 2006
16Companies have two choices to increase net
income Grow revenue or reduce lost productivity
Revenue growth equivalent
Lost productivity savings
17The Real Costs of Ill Health
18Perceived Costs/Program
3,090
762
435
387
172
6
Source IBI 2002 Benefit Benchmarking Data
19The Opportunity Cost of Absence
- What is the real cost of people being away from
work?
20Range of Lost Productivity From Absence
Source IBI 2002 Benefit Benchmarking Data
21Real Costs/Program
3,090
2,505
1,796
660
392
178
Source 2002 IBI Full-cost Benefit Data
Nicholson Lost-productivity
Modifier
22Top 15 Causes of Lost Work Time
Source HPQ
23(No Transcript)
24Managing the Economic Burden of Ill Health
Source Beyond Cost Containment, IBI - 2005
25The Impact of Pharmaceutical Plan Design
26Average Medication Adherence
27Impact of Out-of-Pocket Cost
28Filling at least one Disease Modifying script
reduces STD incidence
-36
29Filling at least one Disease Modifying script
reduces STD duration
-6
30Impact on Lost Productivity Costs-- No Script
Group --
-19
-26
31Where to from Here?
- Do benefits and risk managers talk?
- Do you attempt to control costs or to manage
health? - Are you ready to begin measuring health and
productivity outcomes? - How will you get business-relevant outcomes
information? - Focus health-plan discussion on value
32What Does Good Look Like?
- Health Productivity Management on the National
Scene
33Pitney Bowes
- World-class IDM Pioneer1999 IBI case study
- 78 of PBs healthcare costs relate to chronic
illness - PB Every benefits-design issue is a long-term
investment in higher productivity - Uses sophisticated, data-driven decision making
- Longer time horizon in assessing behavioral
impact of benefits design than other companies - Value-based medicine reward quality medicine
that pays off to the companys bottom line
prevention, screening, right treatment at the
right time
34Pitney Bowes - Decreased Pharmacy Copays to
Increase the Value of Health Benefits
New Rx Access Benefit
Traditional Rx Benefit
Tier 1 10 copay
Tier 1 10 copay
Most generic drugs
Most generic drugs and all brand-name drugs for
- Asthma
- Diabetes
- Hypertension
Tier 2 30 copay
- Most preferred brand-name
- drugs, including those for
-
- Asthma
- Diabetes
- Hypertension
Tier 2 30 copay
Most preferred brand-name drugs for all other
diseases
Tier 3 50 copay
- Nonpreferred brand-name
- drugs, including those for
Tier 3 50 copay
Nonpreferred brand-name drugs for all other
diseases
- Asthma
- Diabetes
- Hypertension
Hom D. Value Based Benefits Designs. Available
at http// http//www.sph.umich.edu/vbidcenter/sy
mposia.htm. Accessed November 30, 2006.
35PBs Diabetes Results (after 3 Years)
- Despite the lower copays (and higher employer
cost per script), PB had these diabetes results - Medication adherence rates ? significantly
- Average total Pharma costs ? 7
- Emergency room visits ? 26
- Hospital admissions up slightly, but below
demographically adjusted benchmark - Direct health care costs per plan participant for
diabetes ? 6 - STD days among employees in the diabetes program
? approx. 50
36PBs Overall Results
- A markedly slowed increase in overall health
costs per plan participant - Attributes to strategic redesign of drug benefits
for diabetes, asthma and hypertension - Attributes also to lower copayments for physician
office visits, availability of free or low-cost
preventive screening and other enhancements
37The Asheville Project Education, Lowered
Pharmacy Copays, Professional Coaching
- Started in 1997 with 85 employees from 2
employers now gt1000 employees with diabetes,
asthma, hypertension, and lipid-therapy
management enrolled from 5 employers - Employers/payers remove barriers to improve
adherence and continuity of health maintenance - Copay waivers
- Labs without copays
- Glucose meters
- Local networks of trained pharmacists help
patients manage their care and are reimbursed for
this service
38Decreased Total Medical Costs
39Decrease in Sick Days Taken
Source Cranor CW et al. J Am Pharm Assoc.
200343173-184
40Asheville Project - Clinical Outcomes
Patients With Clinical Measure Improvement
Compared With Baseline at 6 Months
Source Cranor CW et al. J Am Pharm Assoc.
200343173-184
41International Truck and Engine
- In late 2001 ITE found musculoskeletal
disabilities to be a major problem - Significant share of WC costs
- Often unnecessary referrals to orthopedic
specialists or not referred when appropriate. - EEs frequently given sedating controlled-substance
pain relievers that hurt safe return to work.
- ITE developed a unique solution involving PCP
- education, use of medical-treatment
guidelines, - improved employee communications and ITE
- on-site medical facilities.
42ITE Program
- Establish baseline data
- EE status/RTW report for PCP
- Evidence-based medicine training for PCPs
- Give PCP job functions
- Emphasized to PCP importance of timely and proper
use of medications - On-site PT facilities for safe, early RTW
- Communicate, communicate, communicate to EEs,
PCPs, operations and senior management
43ITE Program Results
Musculoskeletal Disability Cases Costs/Case
44ITE Program Results
- Lost workdays per injury ? 21
- Days lost per FTE were cut in half
- Light-duty days almost doubled from 6.1 to 11.1
days per injury - On-site physical therapy ? 50
- Productivity gains through reduced lost time 99
more trucks built per year
45Lessons Learned
- Data Baseline and track all relevant results
- Align incentives to bottom-line value
- Dont discourage best medicine
- Communicate/Educate PCPs, EEs, operations,
senior management - Keep the focus on real costs include lost time
and lost productivity